Literature DB >> 11062687

Identification of THW, a putative new tumor suppressor gene.

T Hildebrandt1, J Preiherr, N Tarbé, S Klostermann, G N Van Muijen, U H Weidle.   

Abstract

Differential Display between metastasizing and non-metastasizing human melanoma cell lines NMCL-1 and 530 led to the identification of a putative transmembrane receptor, designated as THW, which is down-regulated in the metastasizing cell line. THW is composed of 193 aa, exhibits four putative transmembrane domains and does not reveal any homology to other proteins. Down-regulation of THW is correlated with metastatic capacity of melanoma cell lines. THW was down-regulated in mammary carcinoma cell lines compared with cell lines derived from non-malignant mammary epithelium, in pancreas cell lines derived from metastases compared with a cell line derived from a primary tumor and in several tumor tissues compared with normal tissues. The function of THW as a tumor suppressor is emphasized by the location of the THW gene on chromosome 6q. LOH for this region has been reported in malignant melanoma and prostate, pancreas, uterine and mammary carcinomas.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11062687

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

1.  The p53 Target Gene SIVA Enables Non-Small Cell Lung Cancer Development.

Authors:  Jeanine L Van Nostrand; Alice Brisac; Stephano S Mello; Suzanne B R Jacobs; Richard Luong; Laura D Attardi
Journal:  Cancer Discov       Date:  2015-03-26       Impact factor: 39.397

2.  Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells.

Authors:  Carl E Allen; Liunan Li; Tricia L Peters; Hon-Chiu Eastwood Leung; Alexander Yu; Tsz-Kwong Man; Sivashankarappa Gurusiddappa; Michelle T Phillips; M John Hicks; Amos Gaikwad; Miriam Merad; Kenneth L McClain
Journal:  J Immunol       Date:  2010-03-10       Impact factor: 5.422

3.  Bypass of senescence by the polycomb group protein CBX8 through direct binding to the INK4A-ARF locus.

Authors:  Nikolaj Dietrich; Adrian P Bracken; Emmanuelle Trinh; Charlotte K Schjerling; Haruhiko Koseki; Juri Rappsilber; Kristian Helin; Klaus H Hansen
Journal:  EMBO J       Date:  2007-03-01       Impact factor: 11.598

4.  Deficiency of the p53/p63 target Perp alters mammary gland homeostasis and promotes cancer.

Authors:  Rachel L Dusek; Jamie L Bascom; Hannes Vogel; Sylvain Baron; Alexander D Borowsky; Mina J Bissell; Laura D Attardi
Journal:  Breast Cancer Res       Date:  2012-04-20       Impact factor: 6.466

5.  PERP expression stabilizes active p53 via modulation of p53-MDM2 interaction in uveal melanoma cells.

Authors:  L Davies; D Spiller; M R H White; I Grierson; L Paraoan
Journal:  Cell Death Dis       Date:  2011-03-31       Impact factor: 8.469

6.  DCAF13 promotes breast cancer cell proliferation by ubiquitin inhibiting PERP expression.

Authors:  Bao-Qian Shan; Xiao-Min Wang; Li Zheng; Yao Han; Jie Gao; Meng-Dan Lv; Yi Zhang; Yi-Xuan Liu; Han Zhang; Hao-Sa Chen; Lei Ao; Yin-Li Zhang; Xiang Lu; Zhong-Jie Wu; Ying Xu; Xuan Che; Michal Heger; Shu-Qun Cheng; Wei-Wei Pan; Xin Zhang
Journal:  Cancer Sci       Date:  2022-03-18       Impact factor: 6.518

Review 7.  The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer.

Authors:  Xiaoge Hu; Xiangxiang Lei; Jinhui Guo; Wen Fu; Wen Sun; Qiliang Lu; Wei Su; Qiuran Xu; Kangsheng Tu
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738

8.  p63 is required beside p53 for PERP-mediated apoptosis in uveal melanoma.

Authors:  Raheela Awais; David G Spiller; Michael R H White; Luminita Paraoan
Journal:  Br J Cancer       Date:  2016-09-01       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.